BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane.

British journal of cancer

Volumn 111, Issue 7, 2014, Pages 1269-1274

  Kotsopoulos, J ^a   Zhang, S ^a   Akbari, M ^a   Salmena, L ^a   Llacuachaqui, M ^a   Zeligs, M ^a   Sun, P ^a   Narod, S A ^a  

^a Bioresponse LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' DIINDOLYLMETHANE; 3,3'-DIINDOLYLMETHANE; ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; INDOLE DERIVATIVE; MESSENGER RNA;

ADULT; AGED; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; MUTATION; ORAL DRUG ADMINISTRATION; UPREGULATION;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICARCINOGENIC AGENTS; BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; INDOLES; MIDDLE AGED; MUTATION; RNA, MESSENGER; UP-REGULATION;

EID: 84909988668     PISSN: None     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.391     Document Type: Article

References (0)